BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 27909743)

  • 41. Exaggerated production of nitric oxide (NO) and increases in inducible NO-synthase mRNA levels induced by the pro-inflammatory cytokine interleukin-1beta in vascular smooth muscle cells of elderly rats.
    Chan GH; Fiscus RR
    Exp Gerontol; 2004 Mar; 39(3):387-94. PubMed ID: 15036398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nitric oxide synthase induction by ouabain in vascular smooth muscle cells from normotensive and hypertensive rats.
    Pacheco ME; Marín J; Manso AM; Rodríguez-Martínez MA; Briones A; Salaices M; Redondo J
    J Hypertens; 2000 Jul; 18(7):877-84. PubMed ID: 10930185
    [TBL] [Abstract][Full Text] [Related]  

  • 43. L-arginine attenuates Interleukin-1β (IL-1β) induced Nuclear Factor Kappa-Beta (NF-κB) activation in Caco-2 cells.
    Meng Q; Cooney M; Yepuri N; Cooney RN
    PLoS One; 2017; 12(3):e0174441. PubMed ID: 28334039
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An anti-ulcer drug, geranylgeranylacetone, suppresses inducible nitric oxide synthase in cultured vascular smooth muscle cells.
    Yamamoto K; Sarukawa M; Ito T; Aoki H; Ichida M; Shimada K
    J Hypertens; 2005 Oct; 23(10):1847-53. PubMed ID: 16148608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selectivity of the diacylglycerol kinase inhibitor 3-[2-(4-[bis-(4-fluorophenyl)methylene]-1-piperidinyl)ethyl]-2, 3-dihydro-2-thioxo-4(1H)quinazolinone (R59949) among diacylglycerol kinase subtypes.
    Jiang Y; Sakane F; Kanoh H; Walsh JP
    Biochem Pharmacol; 2000 Apr; 59(7):763-72. PubMed ID: 10718334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Arginine vasopressin inhibits nitric oxide synthesis in cytokine-stimulated vascular smooth muscle cells.
    Yamamoto K; Ikeda U; Okada K; Saito T; Shimada K
    Hypertens Res; 1997 Sep; 20(3):209-16. PubMed ID: 9328802
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of 17beta-oestradiol on cytokine-induced nitric oxide production in rat isolated aorta.
    Kauser K; Sonnenberg D; Diel P; Rubanyi GM
    Br J Pharmacol; 1998 Mar; 123(6):1089-96. PubMed ID: 9559891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Glutamine inhibits interleukin-1beta induced nitric oxide production and inducible nitric oxide synthase expression: experiment with cultured rat hepatocytes].
    Lu J; Wang XY; Tang WH
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):695-8. PubMed ID: 19595066
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of nuclear factor-kappaB activation in cytokine- and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells.
    Katsuyama K; Shichiri M; Marumo F; Hirata Y
    Endocrinology; 1998 Nov; 139(11):4506-12. PubMed ID: 9794459
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hemin activation of an inducible isoform of nitric oxide synthase in vascular smooth-muscle cells.
    Suzuki S; Kassell NF; Lee KS
    J Neurosurg; 1995 Nov; 83(5):862-6. PubMed ID: 7472555
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of barbiturates on the expression of the inducible nitric oxide synthase in vascular smooth muscle.
    Kessler P; Kronemann N; Hecker M; Busse R; Schini-Kerth VB
    J Cardiovasc Pharmacol; 1997 Dec; 30(6):802-10. PubMed ID: 9436821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential regulation of L-arginine transport and inducible NOS in cultured vascular smooth muscle cells.
    Durante W; Liao L; Schafer AI
    Am J Physiol; 1995 Mar; 268(3 Pt 2):H1158-64. PubMed ID: 7535004
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Involvement of inducible nitric oxide synthase and estrogen receptor ESR2 (ERβ) in the vascular dysfunction in female type 1 diabetic rats.
    Sartoretto SM; Santos FF; Costa BP; Ceravolo GS; Santos-Eichler R; Carvalho MHC; Fortes ZB; Akamine EH
    Life Sci; 2019 Jan; 216():279-286. PubMed ID: 30447304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Garlic attenuates nitric oxide production in rat cardiac myocytes through inhibition of inducible nitric oxide synthase and the arginine transporter CAT-2 (cationic amino acid transporter-2).
    Schwartz IF; Hershkovitz R; Iaina A; Gnessin E; Wollman Y; Chernichowski T; Blum M; Levo Y; Schwartz D
    Clin Sci (Lond); 2002 May; 102(5):487-93. PubMed ID: 11980565
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of nitric oxide synthase abrogates lipopolysaccharides-induced up-regulation of L-arginine uptake in rat alveolar macrophages.
    Hammermann R; Stichnote C; Closs EI; Nawrath H; Racké K
    Br J Pharmacol; 2001 Jun; 133(3):379-86. PubMed ID: 11375254
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Catalase potentiates interleukin-1beta-induced expression of nitric oxide synthase in rat vascular smooth muscle cells.
    Guikema BJ; Ginnan R; Singer HA; Jourd'heuil D
    Free Radic Biol Med; 2005 Mar; 38(5):597-605. PubMed ID: 15683716
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of redox signaling and poly (adenosine diphosphate-ribose) polymerase activation in vascular smooth muscle cell growth inhibition by nitric oxide and peroxynitrite.
    Huang J; Lin SC; Nadershahi A; Watts SW; Sarkar R
    J Vasc Surg; 2008 Mar; 47(3):599-607. PubMed ID: 18295111
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exogenous NG-hydroxyl-L-arginine causes nitrite production in vascular smooth muscle cells in the absence of nitric oxide synthase activity.
    Schott CA; Bogen CM; Vetrovsky P; Berton CC; Stoclet JC
    FEBS Lett; 1994 Mar; 341(2-3):203-7. PubMed ID: 7511114
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ambient pressure upregulates nitric oxide synthase in a phosphorylated-extracellular regulated kinase- and protein kinase C-dependent manner.
    Vouyouka AG; Jiang Y; Rastogi R; Basson MD
    J Vasc Surg; 2006 Nov; 44(5):1076-84. PubMed ID: 17098545
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Natriuretic peptide-augmented induction of nitric oxide synthase through cyclic guanosine 3',5'-monophosphate elevation in vascular smooth muscle cells.
    Marumo T; Nakaki T; Hishikawa K; Hirahashi J; Suzuki H; Kato R; Saruta T
    Endocrinology; 1995 May; 136(5):2135-42. PubMed ID: 7536663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.